Isoagglutinins following ABO-Incompatible Bone Marrow Transplantation
- 1 April 1992
- journal article
- research article
- Published by Wiley in Vox Sanguinis
- Vol. 62 (3) , 176-179
- https://doi.org/10.1111/j.1423-0410.1992.tb01194.x
Abstract
Isoagglutinins were investigated following ABO-incompatible bone marrow transplantation. In major incompatibility anti-A tends to require more time to disappear than anti-B. Correspondingly, A erythrocytes require more time to become demonstrable. There is no such difference in major plus minor incompatibility. In minor incompatibility, isoagglutinins against the recipient blood group may be produced early after bone marrow transplantation, which then give way to a possibly lifelong tolerance for the recipient's old blood group.Keywords
This publication has 12 references indexed in Scilit:
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- Hemotherapy in patients undergoing blood group incompatible bone marrow transplantationTransfusion, 1983
- ABH incompatible bone marrow transplantation: removal of erythrocytes by starch sedimentationBritish Journal of Haematology, 1983
- Bone Marrow Transplantation in West Germany in Patients with LeukemiaPublished by Springer Nature ,1983
- ABO-INCOMPATIBLE BONE-MARROW TRANSPLANTATION: REMOVAL OF RED BLOOD CELLS FROM DONOR MARROW AVOIDING RECIPIENT ANTIBODY DEPLETIONThe Lancet, 1982
- ABO-INCOMPATIBLE MARROW TRANSPLANTSTransplantation, 1982
- ABH Antigens and Bone Marrow TransplantationBritish Journal of Haematology, 1980
- ABO blood group system and bone marrow transplantationBlood, 1977
- Cellular basis of tolerance in neonatally induced mouse chimeras.The Journal of Experimental Medicine, 1975
- Cell Antigens and Cell SpecializationBlood, 1963